Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Oral solid composition of abiraterone and preparation method thereof

A technology of abiraterone and abiraterone acetate, applied in the direction of drug combination, medical preparations containing active ingredients, pharmaceutical formulas, etc.

Inactive Publication Date: 2013-12-18
CHONGQING PHARMA RES INST
View PDF2 Cites 29 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007]Although abiraterone acetate is effective in oral treatment of advanced prostate cancer, its physical characteristics of compressibility and poor solubility have brought serious problems to the development of formulations

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral solid composition of abiraterone and preparation method thereof
  • Oral solid composition of abiraterone and preparation method thereof
  • Oral solid composition of abiraterone and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1~6

[0061] The prescription of embodiment 1~6 sees table 1:

[0062] The prescription of table 1 embodiment 1~6

[0063] Example Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Average particle size of abiraterone acetate particles 1.024μm 3.133μm 9.968μm 20.225μm 29.873μm 50.325μm Abiraterone acetate 250mg 250mg 250mg 250mg 250mg 250mg lactose 200mg 200mg 200mg 200mg 200mg 200mg microcrystalline cellulose 160mg 160mg 160mg 160mg 160mg 160mg Croscarmellose Sodium 40mg 40mg 40mg 40mg 40mg 40mg povidone 30mg 30mg 30mg 30mg 30mg 30mg Magnesium stearate 5mg 5mg 5mg 5mg 5mg 5mg

[0064] Preparation Process:

[0065] 1. Take the abiraterone acetate bulk drug (also known as the original drug or raw material, the same below) with the above-mentioned average particle size for later use;

[0066] 2. Pass the lactose, mi...

Embodiment 7~12

[0081] The prescription of embodiment 7~12 sees table 4:

[0082] The prescription form of table 4 embodiment 7~12

[0083] Example Example 7 Example 8 Example 9 Example 10 Example 11 Example 12 Average Particle Size of Abiraterone Acetate 5.492μm 5.492μm 5.492μm 12.462μm 12.462μm 12.462μm Abiraterone acetate 250mg 250mg 62.5mg 1000mg 125mg 500mg lactose 150mg —— —— 240mg 300mg 100mg microcrystalline cellulose 100mg —— 180mg —— 200mg 100mg Mannitol —— 200mg —— —— —— —— starch —— —— 150mg 100mg —— —— pregelatinized starch —— 120mg —— —— —— —— Croscarmellose Sodium 40mg —— —— 20mg 25mg —— Crospovidone —— 30mg —— —— —— 40mg Sodium carboxymethyl starch —— —— 45mg 20mg —— —— povidone 30mg —— 35mg —— —— 35mg hypromellose —— 15mg —— 15mg 10mg —— Sodium dodecyl sulfate 20mg —...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an oral solid composition of abiraterone and a preparation method thereof. The composition contains abiraterone acetate with a particle size of 1-30 micrometers and pharmaceutic adjuvants.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and in particular relates to an oral solid pharmaceutical composition of abiraterone and a preparation method thereof. The composition comprises abiraterone acetate with a particle size of 1-30um and pharmaceutical auxiliary materials. technical background [0002] Abiraterone acetate, chemical name: (3β)-17-(3-pyridyl)-androst-5,16-dien-3-ol acetate, its chemical structure is shown in formula I . [0003] [0004] [0005] Abiraterone acetate can be converted into abiraterone in the body. Abiraterone is a cytochrome oxidase P450 (CYP450)c17 inhibitor, which reduces androgen levels by inhibiting the key enzyme in androgen synthesis-CYP450c17, so , Abiraterone not only inhibits the androgen produced by the testes but also other parts of the body such as the adrenal gland. [0006] Androgens can promote the growth of prostate cancer cells. At present, castration therapy, including ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/20A61K31/58A61P13/08A61P35/00
Inventor 王立张涛
Owner CHONGQING PHARMA RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com